Abbott announced it has exercised an option to acquire Cephea Valve Technologies Inc., which is developing a minimally invasive mitral valve replacement system.
According to a press release from Abbott, the company invested in Cephea in 2015, at which time the option to acquire was created. Financial terms were not disclosed.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.